International consumer group slates drug companies' marketing practices
BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7557.14-b (Published 29 June 2006) Cite this as: BMJ 2006;333:14- Michael Day
- London
Drug companies continue to pull the wool over the eyes of patients and doctors, concludes a new report from Consumers International. The report lambasts the industry for its lack of transparency and unscrupulous marketing.
Consumers International has called on governments to rein in the industry's practices that “misinform consumers about the benefits of the drugs they are buying.”
It warns that drug companies are adopting new ways to influence consumers, such as sponsoring patients' groups and funding disease awareness campaigns, as well as using old methods such as offering hospitality to medical experts or “opinion leaders.”
Richard Lloyd, the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.